Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Immunology | Pulmonary/Respiratory Diseases | Vaccines | Infections and Infectious Diseases
Clinical Trials: Influenza
A listing of clinical trials currently looking for volunteers to enroll in Influenza studies. Click on the closest city to find more detailed information on a research study in your area.
Arkansas
Little Rock :
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
California
Beverly Hills :
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Burbank :
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Los Angeles :
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
Los Angeles :
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
San Diego :
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
View More »
San Diego :
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
Stanford : Stanford University School of Medicine
Seasonal Influenza HA DNA (VRC) With Trivalent Inactivated Vaccine (TIV) Administered ID or IM in Healthy Adults Ages 18-70 Years
Colorado
Denver :
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Connecticut
Trumbull :
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Florida
Pinellas Park : Radiant Research - St. Petersburg
Clinical Research for Flu Vaccine
View More »
Coral Gables : Clinical Research of South Florida
Bifidobacterium Lactis HN019 Supplementation for Prevention of Influenza Infection in Healthy Adults
Debary :
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Miami : Miami Research Associates
Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49 Years
Miami : Miami Research Associates
T-705a Multicenter Study in Adults Subjects With Uncomplicated Influenza
South Miami :
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
Tamarac :
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Illinois
Chicago :
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
Chicago :
An Influenza Resistance Information Study (IRIS)
Maywood :
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
Iowa
Iowa City : University of Iowa Hospitals & Clinics
Seasonal Influenza HA DNA (VRC) With Trivalent Inactivated Vaccine (TIV) Administered ID or IM in Healthy Adults Ages 18-70 Years
Kansas
Lenexa : Johnson County Clin-Trials
Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49 Years
Wichita :
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
Wichita :
A Study of Intravenous Tamiflu (Oseltamivir) in Children With Influenza
Kentucky
Louisville :
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
Louisiana
New Orleans :
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
Maryland
Baltimore : SNBL Clinical Pharmacology Center
Safety and Pharmacokinetics Study of Human Monoclonal Antibody (FGI-101-1A6)
Massachusetts
Brockton : Beacon Clinical Research
65+ Flu Vaccine Research Study
View More »
Boston :
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
Springfield :
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Michigan
Detroit :
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
Detroit :
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Rochester : Remedica, LLC
Bifidobacterium Lactis HN019 Supplementation for Prevention of Influenza Infection in Healthy Adults
Missouri
Kansas City : Dybedal Clinical Research Center
Influenza Study
View More »
St Louis :
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
St. Louis : Saint Louis University - Doisy Research Center
Seasonal Influenza HA DNA (VRC) With Trivalent Inactivated Vaccine (TIV) Administered ID or IM in Healthy Adults Ages 18-70 Years
Nebraska
Omaha :
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
Omaha :
A Study of Intravenous Tamiflu (Oseltamivir) in Children With Influenza
New Jersey
New Brunswick :
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
New York
Rochester : Rochester Clinical Research
Elderly Flu Vaccine
View More »
Bronx :
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
Brooklyn :
A Study of Intravenous Tamiflu (Oseltamivir) in Children With Influenza
New York :
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
New York :
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
Stony Brook :
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
Stony Brook :
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
Syracuse :
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
North Carolina
Cary : PMG Research of Cary
Flu Vaccine Coming in October
Charlotte : PMG Research of Charlotte
Flu Vaccine Coming in October
Hickory : PMG Research of Hickory
Flu Vaccine Coming in October
Raleigh : PMG Research of Raleigh
Flu Vaccine Coming in October
Salisbury : PMG Research of Salisbury
Flu Vaccine Coming in October
Wilmington : PMG Research of Wilmington
Flu Vaccine Coming in October
Winston-Salem : PMG Research of Winston-Salem
Flu Vaccine Coming in October
View More »
Charlotte :
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
Charlotte :
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Durham :
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
Durham :
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
North Dakota
Bismarck : St. Alexius Medical Center
A study of an investigational medication for the treatment of the flu
Ohio
Akron :
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
Toledo :
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Oklahoma
Tulsa : Vital Prospects Clinical Research Institute, P.C.
Seasonal Flu
View More »
Oklahoma City :
A Study of Intravenous Tamiflu (Oseltamivir) in Children With Influenza
Oregon
Pennsylvania
Duncansville :
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
Philadelphia :
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
Pittsburgh :
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
Pittsburgh :
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Pittsburgh : University of Pittsburgh, Division of Geriatric Medicine
Randomized Trial of High Dose Influenza Vaccine in Long Term Care Setting
Rhode Island
Providence :
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
Tennessee
Texas
San Antonio : Sun Research Institute
Are you suffering from Flu-like symptoms?
San Antonio : Sun Research Institute
Are you suffering from Flu-like symptoms?
View More »
Dallas :
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
Dallas :
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
Houston :
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
Houston :
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Houston : Baylor College of Medicine
Seasonal Influenza HA DNA (VRC) With Trivalent Inactivated Vaccine (TIV) Administered ID or IM in Healthy Adults Ages 18-70 Years
Virginia
Richmond :
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
Australia
Brisbane : Taringa 7 Day Medical Practice
Validation of the Respirio Flu Test for the Rapid Identification of Influenza A/B
Brisbane : Capalaba Medical Centre
Validation of the Respirio Flu Test for the Rapid Identification of Influenza A/B
Westmead :
An Influenza Resistance Information Study (IRIS)
Belgium
Bruxelles :
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Leuven :
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Bulgaria
Plovdiv :
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Canada
Burlington : Aviva Medical Clinical Trials Group
Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)
Courtice : Co-Medica Research Network
Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)
Halifax : QEII Health Science Centre
Sentinel Surveillance for Influenza Requiring Hospital Admission Canadian Adults
Hamilton : McMaster
Sentinel Surveillance for Influenza Requiring Hospital Admission Canadian Adults
Kitchener : Dr. Sameh Fikry Medicine Professional Corporation
Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)
View More »
London : Schacter Medicine Professional Corporation
Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)
Mirabel : Omnispec Clinical Research Inc.
Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)
Montreal : MUCH
Sentinel Surveillance for Influenza Requiring Hospital Admission Canadian Adults
Montreal : Metropolitan Clinical Research Centre
Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)
Oshawa : Taunton Health Centre
Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)
Ottawa : Ottawa General
Sentinel Surveillance for Influenza Requiring Hospital Admission Canadian Adults
Pickering : Steeple Hill Medical Centre
Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)
Quebec : CHUl/CHUQ
Sentinel Surveillance for Influenza Requiring Hospital Admission Canadian Adults
Quebec : ALPHA Recherche Clinique
Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)
Saint John : Saint John Regional Hospital
Sentinel Surveillance for Influenza Requiring Hospital Admission Canadian Adults
Sarnia : London Road Diagnostic Clinic and Medical Centre
Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)
Sherbrooke : CHUS
Sentinel Surveillance for Influenza Requiring Hospital Admission Canadian Adults
St. John's : Paradise Medical Clinic
Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)
Strathroy : DCTM Clinical Trials Group Ltd.
Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)
Surrey : Fraser Health Authority
Adjuvanted Influenza Vaccine Effectiveness in the Elderly (65+Yrs)
Toronto : Mount Sinai Hospital
A Time-motion Study Comparing Self- to Nurse-vaccination With Influenza Vaccine
Toronto : Mount Sinai
Sentinel Surveillance for Influenza Requiring Hospital Admission Canadian Adults
Toronto : Dr. Anil Gupta
Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)
Vancouver : Vancouver General
Sentinel Surveillance for Influenza Requiring Hospital Admission Canadian Adults
China
Zhengzhou : Henan Center for Diseases Control and Prevention
The Immunogenicity and Safety of 2012-2013 Trivalent Seasonal Influenza Vaccine
Czech Republic
Decin : GSK Investigational Site
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345
Jindrichuv Hradec : GSK Investigational Site
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345
Lipnik nad Becvou : GSK Investigational Site
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345
Nachod : GSK Investigational Site
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345
Odolena voda : GSK Investigational Site
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345
View More »
Ostrava - Poruba : GSK Investigational Site
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345
Parah 5 :
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Pardubice : GSK Investigational Site
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345
Praha 6 : GSK Investigational Site
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345
Tabor :
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Terezin :
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Zlin :
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Estonia
Tallinn :
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Tartu :
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
France
Bron :
An Influenza Resistance Information Study (IRIS)
Garches :
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
Paris :
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
Tours :
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Germany
Berlin :
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Berlin :
An Influenza Resistance Information Study (IRIS)
München :
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Hong Kong
Shatin :
An Influenza Resistance Information Study (IRIS)
Hungary
Budapest :
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Debrecen :
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Eger :
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
Gyor :
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Gyula :
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
View More »
Miskolc :
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
Nyiregyhaza :
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
Pecs :
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
Pecs :
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Szeged :
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
Szekesfehervar :
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Szolnok :
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Szombathely :
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
Veszprem :
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Israel
Jerusalem : Hadassah medical center
A Study to Assess the Safety and Immunogenicity of an IM Influenza Vaccine (Multimeric-001) Followed by Administration of TIV to Elderly Volunteers
Petach Tikva :
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Tel Hashomer :
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Italy
Brescia :
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Milano :
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
Monza :
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Roma :
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
Roma :
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Kenya
Kisumu : KEMRI/CDC- IEIP surveillance-Asembo
Seasonal Influenza Vaccine Effectiveness Study in Kenya
Nairobi : KEMRI/CDC IEIP surveillance- Kibera
Seasonal Influenza Vaccine Effectiveness Study in Kenya
Latvia
Riga :
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Lithuania
Kaunas :
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
Kaunas :
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Klaipeda :
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Siauliai :
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Vilnius :
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Norway
Sandnes :
An Influenza Resistance Information Study (IRIS)
Poland
Bialystok :
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Bydgoszcz :
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Chorzow :
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
Debica : GSK Investigational Site
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345
Katowice : GSK Investigational Site
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345
View More »
Krakow :
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Lodz :
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Radom :
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
Siemianowice Slaskie : GSK Investigational Site
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345
Warszawa :
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
Wroclaw :
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Romania
Bucharest :
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
Russian Federation
Saratov :
A Study of Arbidol (Umifenovir) for Treatment and Prophylaxis of Influenza and Common Cold
Spain
Alicante :
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
Almería :
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
Antequera/Málaga : GSK Investigational Site
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345
Blanes (Girona) : GSK Investigational Site
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345
Castellón : GSK Investigational Site
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345
View More »
Centelles (Barcelona) : GSK Investigational Site
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345
Madrid :
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
Madrid :
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Madrid : GSK Investigational Site
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345
Paiporta, Valencia : GSK Investigational Site
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345
Quart de Poblet, Valencia : GSK Investigational Site
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345
Santiago de Compostela : GSK Investigational Site
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345
Sevilla : GSK Investigational Site
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345
Valencia : GSK Investigational Site
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345
Taiwan
Taoyuan County : Chang Gung Memorial Hospital at Linkuo
A Trial to Assess the Immunogenicity and Safety of the Trivalent Virosomal Influenza Vaccine, Formulation of 2012-2013, in Healthy Subjects Aged Over 3 Years Old to 18 Years Old
United Kingdom
Belfast : GSK Investigational Site
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345
Bristol : GSK Investigational Site
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345
Coventry : GSK Investigational Site
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345
London :
Influenza Virus Challenge Study to Test Monoclonal Antibody TCN-032 as a Treatment for Influenza
